Multilingual content from IBKR

Close Navigation
Learn more about IBKR accounts

Philips Shares Slump After Update On Recall Of Respiratory, Sleep Devices

Posted November 15, 2021 at 11:15 am
Vandana Singh

Koninklijke Philips NV PHG said it is in discussions with the FDA after a new inspection of one of its facilities.

Philips in September estimated it would replace up to 4 million ventilators and respiratory devices because of a polyurethane foam part that might degrade and become toxic.

On November 12, the FDA had obtained new information during inspections of the company’s Murraysville, PA facility.

The FDA asked Philips to conduct more tests on the foam used in the recalled ventilators and said the company has not sufficiently demonstrated that other devices containing the foam should not also be recalled. 

It also said Philips’ procedures for design change might not be adequate.

“We will work closely with the FDA to clarify and follow up on the inspectional findings and its recent requests related to comprehensive testing,” Philips CEO Frans van Houten said in a statement.

“Until we have concluded these discussions, we are not able to publicly provide further details.”

It said it expected to complete its testing of the foam in the fourth quarter.

The company has been using a replacement silicone-based foam which must now also undergo further safety testing.

Price Action: 

PHG shares are down 10.7% at $42.52 during the premarket session on the last check Monday.

Originally Posted on November 15, 2021 – Philips Shares Slump After Update On Recall Of Respiratory, Sleep Devices

Disclosure: Benzinga

© 2022 Benzinga does not provide investment advice. All rights reserved.

Disclosure: Interactive Brokers

Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Benzinga and is being posted with its permission. The views expressed in this material are solely those of the author and/or Benzinga and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

IBKR Campus Newsletters

This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.